Anna Filonenko, DrPH, MSc (Econ), is a seasoned expert in health economics and patient-centered research, currently serving as the Director of Real-World Evidence Scientist in Rare Disease at Pfizer. With a background that includes roles as Clinical Study Lead at Schering AG and various leadership positions at Bayer, including Director of HEOR in Market Access for Pulmonology and Women's Health, Anna has contributed significantly to evidence generation and market access strategies. Anna’s educational achievements encompass a Doctor of Public Health from Bielefeld University and Master’s and Bachelor’s degrees in Economics from Freie Universität Berlin and Riga Technical University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices